Delivery Order SPE2DB20D2014-SPE2DB25FA32P

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of potassium chloride extended-release capsules, a critical medication for various medical conditions. The contract has a ceiling value of $3,641.65 and a completion date of September 16, 2024. There is no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.40 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,104.43 firm fixed-price delivery order is for the supply of 4560970833 potassium chloride extended-release 8 milliequivalent (MEQ) tablets in 500-count bottles. The contract has a performance period ending on May 18, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,668.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of potassium chloride, a medical product, with a period of performance ending on May 22, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, SPE2DX15D1022|SPE2DX25FUYTF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,854.60 firm fixed-price delivery order is for the supply of 4,566,133,855 units of 10% potassium chloride in 15 ml cups, with a period of performance through October 18, 2024. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains a $999,999,999 Indefinite...
This federal contract award, valued at $10,015.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3301|SPE2DB25FY4GX) for the supply of 4568142788 - POTASSIUM CL 10% (40 MEQ/30 ML) CUP UD 30 ML. The award has a firm fixed price pricing type and an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the...
This federal contract award, valued at $4,712.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Potassium Chloride Extended Release (ER) 20 MEQ Tablets in 500-count bottles. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4560815782 - Potassium Cl ER 20 MEQ Tablet 100s, with a ceiling value of $1,100.40 and a completion date of May 4, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,528.41 firm fixed price delivery order is for the supply of 4564094917 - Potassium Phosphate 45 MMOL/15 ML 15ML, with a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,735.08 firm fixed-price contract is for the supply of Potassium Chloride 10 MEQ/100 ML solution, with a final completion date of September 22, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA32P
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,355.22 for the supply of potassium chloride extended-release tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/11/25, 10:17 AM